Professor Chris Christophi, The University of Melbourne, Department of Surgery, Austin Health (Chair) Professor Jon Emery, Herman Professor of Primary Care, The University of Melbourne, Western Health; Director of Primary Care Collaborative Cancer Trials Group Mr Adrian Fox, Hepatobiliary Surgeon, Eastern Health Associate Professor Sze Ting Lee, Nuclear Medicine Physician, Centre for PET, Austin Health…

Advance Care Planning Australia Allied Health Professions Australia Australasian Association of Nuclear Medicine Specialists Australasian Chapter of Palliative Medicine, Royal Australia College of Physicians Australasian Pancreatic Club Australia and New Zealand Hepatic, Pancreatic and Biliary Association Australian and New Zealand Gastric and Oesophageal Surgery Association Australian and New Zealand Society of Neuroradiology Australian and New…

Alfred Health Cancer Australia Cancer Council Victoria, Strategy and Support Division Cancer Institute New South Wales Concord Repatriation General Hospital New South Wales Consumer representative Department of Health Victoria, Commissioning and System Improvement Division, Cancer Unit National Cancer Expert Reference Group Olivia Newton-John Cancer Wellness and Research Centre St Vincent’s Hospital Melbourne Other stakeholders consulted…

Managing metastatic disease is complex and should therefore involve all the appropriate specialties in a multidisciplinary team including palliative care where appropriate. From the time of diagnosis, the team should offer patients appropriate psychosocial care, supportive care, advance care planning and symptom-related interventions as part of their routine care. The approach should be personalised to…

The treatment team should support the patient to participate in research and clinical trials where available and appropriate. For more information visit the Cancer Australia website.

Cancer is the third leading cause of burden of disease for Aboriginal and Torres Strait Islander people. While Australia’s cancer survival rates are among the best in the world, Aboriginal and Torres Strait Islander people continue to experience a different pattern of cancer incidence and significant disparities in cancer outcomes compared with non-Indigenous Australians. For…

If there is an indication that a patient’s cancer has returned, care should be provided under the guidance of a treating specialist. Each patient should be evaluated to determine if referral to the original multidisciplinary team is necessary. Often referral back to the original multidisciplinary team will not be necessary unless there are obvious aspects…

Treatment will depend on the location, extent of recurrent or residual disease, previous management and the patient’s preferences. In managing people with pancreatic cancer, treatment may include these options: surgery stenting chemotherapy radiation therapy intra-arterial therapies percutaneous ablation pain management palliative care. The potential goals of treatment should be discussed, respecting the patient’s cultural values.…

Clinical trials may help improve palliative care and in managing a patient’s symptoms of advanced cancer (Cancer Council Victoria 2019). The treatment team should support the patient to participate in research and clinical trials where available and appropriate. For more information visit the Cancer Australia website. See ’Resource list’ for additional clinical trial databases.